Analyst Upgrades: Adobe Systems, Facebook, Eli Lilly

Analysts upwardly revised their ratings on Adobe Systems Incorporated (ADBE), social networking firm Facebook Inc (FB), and drugmaker Eli Lilly and Co (LLY)

Jun 17, 2015 at 9:23 AM
facebook X logo linkedin

Analysts are weighing in today on software giant Adobe Systems Incorporated (NASDAQ:ADBE), social networking firm Facebook Inc (NASDAQ:FB), and drugmaker Eli Lilly and Co (NYSE:LLY). Here's a look at today's bullish brokerage notes on ADBE, FB, and LLY.

  • Shares of ADBE have shed more than 1% in pre-market action, with traders reacting to a downbeat current-quarter forecast. Analysts at Pacific Crest remain upbeat on the tech company's prospects, though, with the firm increasing its price target to $90 from $85 and backing its "overweight" rating. The new target implies expected upside of 12.6% from ADBE's Tuesday close at $79.94. Meanwhile, with Adobe Systems Incorporated shares up about 10% year-to-date -- but churning around familiar resistance in the $80 area -- traders turned skeptical ahead of last night's earnings report. One of the most popular puts in the front-month series is the deep out-of-the-money June 75 strike, with the major options exchanges reporting that most of the 4,448 contracts in residence here were bought to open.

  • Brean hiked its price target on FB to $108 from $100 and reiterated a "buy" recommendation, with the firm apparently looking for the stock to blaze a trail to new highs over the next 12 months. In fact, most brokers have high hopes for FB, based on its 89% "buy" ratings and average 12-month price target of $96.15. Shares of Facebook Inc, which have advanced roughly 26% year-over-year, touched their current record peak of $86.07 back in March, and settled yesterday at $81.06. Following a bout of range-bound price action over the past month, the equity's Bollinger Bands have narrowed and are now just a few points apart -- suggesting FB may be due for a high-volatility breakout.

  • With the stock hovering near 14-year highs, Piper Jaffray started coverage of LLY with an "overweight" endorsement. There could be more bullish notes in store for the outperforming drug stock, as LLY's average 12-month price target of $80.47 stands at a 5.1% discount to Tuesday's finish at $84.78. That said, the security has been edging primarily sideways this week, as it waits for short-term support at its 10-day moving average to catch up with its breakout progress. As of last night's close, the 14-day Relative Strength Index (RSI) for Eli Lilly and Co still stood in overbought territory, at 74 -- suggesting the shares may continue to cool their heels for a while longer before attempting another leg higher.

Target Effortless Triple-Digit Gains Every Sunday Evening For Life!

This is your chance to triple your profit potential on Sunday evenings, without spending all your free time watching the market.

On Sundays, as a Weekend Plus subscriber, you’ll get up to 6 trades every Sunday, each targeting gains of 200% or more.

Start targeting gains like the ones our subscribers have seen recently, including:

213.3% GAIN on AutoNation calls
100.0% GAIN on Monster Beverage calls
100.4% GAIN on Walgreens Boots Alliance puts
100.4% GAIN on ON Semiconductor calls
257.7% GAIN on Dell calls

101.0% GAIN on Apollo Global Management calls
103.6% GAIN on JP Morgan  Chase calls
105.3% GAIN on DraftKings calls
101.3% GAIN on Airbnb calls
203.0% GAIN on Shopify calls
102.0% GAIN on Cboe Global Markets calls
100.9% GAIN on Boeing calls
102.1% GAIN on Microsoft puts
102.3% GAIN on First Solar calls
101.5% GAIN on PulteGroup calls
101.0% GAIN on Apple calls
209.4% GAIN on NXP Semiconductors calls
100.8% GAIN on Uber Technologies calls
100.4% GAIN on Academy Sports and Outdoors puts
102.2% GAIN on Trade Desk calls
100.8% GAIN on DoorDash calls
100.0% GAIN on Camping World Holdings puts
100.0% GAIN on Cboe Global Markets calls
100.2% GAIN on calls
238.5% GAIN on Oracle calls



Rainmaker Ads CGI